Ocean Biomedical, Inc. SEC filings OCEA

Ocean Biomedical, Inc. has 255 filings in SEC EDGAR's recent list, going back to Jul 19, 2021. Its latest annual report, Form 10-K, was filed on Apr 8, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on May 15, 2025, covering the quarter ended Mar 31, 2025. The most recent current report (Form 8-K) was filed on Aug 5, 2025 (listing notice, officer or director change, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
424B3 Prospectus Aug 16, 2023 —
424B3 Prospectus Aug 16, 2023 —
424B3 Prospectus Aug 3, 2023 —
S-1/A Amended registration statement Jul 6, 2023 —
424B3 Prospectus Jun 23, 2023 —
S-1 Registration statement Jun 22, 2023 —
S-1/A Amended registration statement Jun 15, 2023 —
S-1/A Amended registration statement Jun 1, 2023 —
S-1 Registration statement Apr 21, 2023 —
424B4 Prospectus Sep 16, 2021 —
S-1/A Amended registration statement Sep 2, 2021 —
S-1 Registration statement Jul 19, 2021 —

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OCEA (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
, Emerging growth company
SEC CIK
1869974
Former names
Ocean Biomedical, Inc./DE (until Feb 15, 2023); Aesther Healthcare Acquisition Corp. (until Feb 14, 2023)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.